PubAg

Main content area

Action mechanism of Zuo Gui Yin Decoction's promotion on estradiol production in rats during the peri-menopausal period

Author:
Zhao, Wei, Wen, Hai-Xia, Zheng, Hui-Li, Sun, Shi-Xiao, Sun, Dian-Jun, Ni, Jiang
Source:
Journal of ethnopharmacology 2011 v.134 no.1 pp. 122-129
ISSN:
0378-8741
Subject:
animal models, estradiol, gene expression, immunohistochemistry, in situ hybridization, intragastric administration, mechanism of action, messenger RNA, ovaries, protein synthesis, rats, traditional medicine
Abstract:
AIM OF THE STUDY: Although Zuo Gui Yin Decoction has long been used in Traditional Chinese Medicine to treat menopausal symptoms, the underlying mechanism(s) by which these effects are induced remains to be defined. The aim of this study was to investigate the action mechanism of Zuo Gui Yin Decoction on estradiol production in the rat ovary during peri-menopause. MATERIALS AND METHODS: The peri-menopausal animal model was established by natural aging. Peri-menopausal rats were treated by intragastric administration (ig) with low (13.78gkg⁻¹), middle (20.67gkg⁻¹) or high (31gkg⁻¹) dose of Zuo Gui Yin Decoction per day for 8 weeks. At the 8th weekend, the rats were sacrificed for sampling. Estradiol (E₂) levels in rats’ serum were evaluated by radioimmunoassay (RIA). RT-PCR, in situ hybridization and immunohistochemistry were used to determine mRNA and protein expression of relevant genes. RESULTS: Medium- and high-dose of Zuo Gui Yin Decoction could significantly increase serum estradiol concentration, ovarian CYP19 mRNA levels, and P450ₐᵣₒₘ protein expression in rats during peri-menopause. Zuo Gui Yin Decoction at three different dosages all could promote FSHR expression and the effect of low-dose was the greatest. Zuo Gui Yin Decoction could elevate LRH-1 and ERα expression in a dose dependent manner. CONCLUSIONS: Taken collectively, these findings suggest that Zuo Gui Yin Decoction could promote estradiol production in rat serum during peri-menopausal period through ovarian ERα→LRH-1→CYP19 pathway as well as the ovarian classical FSHR→CYP19 mechanism.
Agid:
494397